| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 709900 | Isoxazolo[5,4-d]-1,2,3-triazin-4(3H)-one, 3-(4-chlorophenyl)-5-methyl- | 0.00845932736945076 | -0.22590707 |
| NSC 725670 | 5,6-Dihydro-5,11-dioxo-6-(2-N-piperazine-1-ethyl)-11H-indeno [1,2-c]isoquinoline | 0.00845932736945076 | -0.26530577 |
| NSC 731805 | Null | 0.00845932736945076 | -0.29093916 |
| NSC 736115 | 6-(3-Azidopropyl)-5,6-dihydro-9-methyl-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline | 0.00845932736945076 | -0.0083593162 |
| NSC 750335 | (E)-3-(2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one | 0.00845932736945076 | 0.16214827 |
| NSC 92915 | ANTINEOPLASTIC-92915 | 0.00845932736945076 | 0.017307187 |
| NSC 2785 | Null | 0.00845932736945082 | 0.11530585 |
| NSC 46213 | Null | 0.00845932736945082 | 0.052641594 |
| NSC 634036 | 4-amino-3-bromo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one | 0.00845932736945082 | -0.33773679 |
| NSC 645306 | Null | 0.00845932736945082 | -7.3583579e-005 |